SPX3,911.74+116.01 3.06%
DIA315.02+8.28 2.70%
IXIC11,607.62+375.43 3.34%

Caribou Biosciences Shares Tumble Following New Data From Phase 1 Trial of CB-010

MT Newswires · 06/10/2022 09:13

Please log in to view news